RS1061808 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"[GWAS:None]"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Saturated fatty acids to total fatty acids percentage | G | β: 0.03 | 4E-52 | PubMed |
| 1,2-dipalmitoyl-gpc (16:0/16:0) levels | G | OR: 0.2 | 2E-37 | PubMed |
| Tenascin-X levels (TNXB.5698.60.3) | G | OR: 0.32 | 8E-37 | PubMed |
| Ratio of saturated fatty acids to total fatty acids | T | β: 0.05 | 6E-34 | PubMed |
| Triacylglycerol (50:2) [NL-18:2] levels | G | OR: 0.27 | 1E-32 | PubMed |
| Average diameter for LDL particles | G | β: 0.02 | 5E-31 | PubMed |
| Triacylglycerol (50:1) [NL-18:1] levels | G | OR: 0.26 | 2E-30 | PubMed |
| Monounsaturated fatty acids to total fatty acids percentage | T | — | 8E-28 | PubMed |
| Pulse pressure | T | OR: 0.28 | 7E-24 | PubMed |
| Pulse pressure | T | OR: 0.25 | 1E-23 | PubMed |
| 1,2-dipalmitoyl-gpc (16:0/16:0) levels | T | OR: 0.1 | 3E-23 | PubMed |
| Pulse pressure | G | β: 0.018 | 1E-22 | PubMed |
| 1,2-dipalmitoyl-gpc (16:0/16:0) levels | T | OR: 0.15 | 4E-22 | PubMed |
| Saturated fatty acids to total fatty acids percentage | T | — | 2E-20 | PubMed |
| Monounsaturated fatty acids to total fatty acids percentage | T | — | 4E-20 | PubMed |
| Plasma 1,2-dipalmitoyl-GPC (16:0/16:0) levels in chronic kidney disease | G | β: 0.047 | 6E-19 | PubMed |
| Phosphatidylcholine_32:0_[M+H]1+/Phosphatidylethanolamine_35:0_[M+H]1+/Phosphatidate_37:1_[M+NH4]1+ levels | T | β: 0.096 | 1E-15 | PubMed |
| Triacylglycerol (50:2) [NL-18:2] levels | G | OR: 0.18 | 2E-15 | PubMed |
| Triacylglycerol (50:1) [NL-18:1] levels | G | OR: 0.18 | 9E-15 | PubMed |
| Phospholipid levels (plasma) | — | OR: 0.9 | 8E-10 | PubMed |